Lantheus Holdings, Inc. manufactures diagnostic and therapeutic products used by clinicians worldwide to treat heart, cancer, and other diseases. Their products include agents used for nuclear medicine and ultrasound exams of the heart, as well as radiotherapeutics to treat adult and pediatric patients. The company has partnerships with several leading healthcare companies and serves a wide range of customers, including hospitals, clinics, and radio pharmacies.